Diabetic retinopathy Eye Diseases Diabetic retinopathy
Conditions
Interventions
The interventions will be at 3 levels of care. The study will introduce pragmatic interventions to initiate a DR care pathway across primary, secondary and tertiary care to ensure:
1. DR screening of
Sponsors
Directorate of Health Services
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People with diabetes
Exclusion criteria
Exclusion criteria: Patients who do not wish to be screened or treated for diabetic retinopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of people with diabetes that were identified, screened and treated for sight threatening retinopathy, measured at 6 months following the interventions | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at 6 months following the interventions: 1. Effectiveness of intervention at primary care level – increase in uptake of DR screening at FHCs as a result of these interventions 2. Effectiveness of interventions at secondary care level – increase in numbers of people treated for STDR in secondary care 3. Effectiveness of intervention at tertiary care level – increase in numbers of patients referred for treatment as a result of DR screening at FHC 4. Factors determining effectiveness of screening and treatment uptake e.g. age groups, gender, FHC 5. Clinical and cost-effectiveness of training and incentivisation of the ASHA workers - completeness of the NCD register in each FHC and the increase in screening and treatment of DR post-training and incentivisation of the ASHA workers Other outcomes: 6. Prevalence of diabetes in each FHC in comparison to the estimated 1:5 adult population in Kerala presumed to be diabetic 7. Prevalence of other complications of diabetes including those with nephropathy, stroke and myocardial infarction identified through the diabetes register 8. Change in life satisfaction questionnaires after the intervention 9. Treatment outcomes of people with STDR 10. Model based economic analysis of the DR screening and treatment pathway | — |
Countries
India
Outcome results
None listed